These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35577013)

  • 21. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
    Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
    Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
    Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
    Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening].
    Liang D; Lin Y; Li H; Hu P; Xu ZF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):106-111. PubMed ID: 32146739
    [No Abstract]   [Full Text] [Related]  

  • 24. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
    Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1065-1068. PubMed ID: 32924102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive prenatal testing for aneuploidy screening.
    Spencer R; Hewitt H; McCarthy L; Wimalasundera R; Pandya P
    BMJ; 2020 Oct; 371():m3930. PubMed ID: 33109517
    [No Abstract]   [Full Text] [Related]  

  • 26. Noninvasive prenatal screening using cell-free DNA.
    Mladenka C
    J Am Assoc Nurse Pract; 2022 Jun; 34(6):789-791. PubMed ID: 35661095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RETIRED: Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.
    Langlois S; Brock JA;
    J Obstet Gynaecol Can; 2013 Feb; 35(2):177-181. PubMed ID: 23470070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
    Borth H; Teubert A; Glaubitz R; Knippenberg S; Kutur N; Winkler T; Eiben B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1407-1414. PubMed ID: 33151425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis.
    Le Bras A; Salomon LJ; Bussières L; Malan V; Elie C; Mahallati H; Ville Y; Vekemans M; Durand-Zaleski I
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):596-603. PubMed ID: 31006923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the factors influencing positive predictive value of noninvasive prenatal testing for chromosome aneuploidies].
    Zhao GY; Dai P; Hu S; Jiao ZH; Kong XD
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2452-2457. PubMed ID: 36000375
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13.
    Bestwick JP; Wald NJ
    PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing: A systematic review and meta-analysis.
    Geppert J; Stinton C; Johnson S; Clarke A; Grammatopoulos D; Taylor-Phillips S
    Prenat Diagn; 2020 Mar; 40(4):454-462. PubMed ID: 31834626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?
    Grati FR; Malvestiti F; Grimi B; Liuti R; Agrati C; Gaetani E; Milani S; Martinoni L; Zanatta V; Gallazzi G; Maggi F; Simoni G
    Prenat Diagn; 2015 Mar; 35(3):308-9. PubMed ID: 25754154
    [No Abstract]   [Full Text] [Related]  

  • 37. False positive result in non-invasive prenatal screening (NIPS).
    Geok-Huey N; Kuo PL; Chang CH
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):772-773. PubMed ID: 30342672
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis.
    Prefumo F; Paolini D; Speranza G; Palmisano M; Dionisi M; Camurri L
    PLoS One; 2019; 14(6):e0218166. PubMed ID: 31188879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatally Diagnosed Fetal Aneuploidy: Natural History and Subsequent Management.
    Murphy NC; Dunne H; Flood K
    Ir Med J; 2020 Mar; 113(3):34. PubMed ID: 32815676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.